Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Apr 25, 2021 10:20pm
169 Views
Post# 33064761

RE:SONA SYNDROME

RE:SONA SYNDROMEI like your play on words, Cote :) But I'm actually happy we have the SONA Syndrome, as you refer to it. The news is solid, the fundamentals are solid and the analyses are all positive ...but that news still has conditions. When it moves, and I sincerely believe it is going to rise significantly, investors won't have to worry about what ifs.

We have been witness to what happened to SONA, we have been witness to a number of companies with rapid antigen tests that found distributors and have still been void of contracts and the last thing we should want for THRM is to rise quickly again solely on potential. Imho if investors continue to wait patiently for the last few pieces of the puzzle including definitive contracts the sp for THRM will launch but more importantly will have the basis for maintaining it. In the meantime a rise of $.10 to $.20 over the next couple of weeks would see the sp more in line with the analyses.

GLTY and GLTE!!!!!

cote101 wrote: THRM Is sick, we got the Sona Syndrome. Nobody beleive what CEO said abou result of our test.
We past 2 tests last week and it is confirmed , we are very infected.

So wait until we got a vaccin from HC or FDA or What ever else other than our CEO

Cote101


<< Previous
Bullboard Posts
Next >>